Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunosuppressive potassium channel blockers from Merck & Co.

July 9, 1998

Multiantigen malaria vaccine evaluated in phase I/II study

July 8, 1998

New immunosuppressants from Merck & Co. acting on potassium channels

July 8, 1998

Chugai to begin clinical testing of anti-IL-6 receptor antibody

July 6, 1998

Asta Medica investigates compounds for immune and allergic disorders

July 1, 1998

Human Genome Sciences presents novel chemokine, its preparation and use

July 1, 1998

Astra devotes significant resources to development of immunomodulatory peptides

June 30, 1998

Astra prepares another series of immunomodulatory peptides

June 29, 1998

Astra discloses immunomodulatory peptides for oral administration

June 26, 1998

Aviron and CSL enter collaboration for FluMist

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...